Sarnak MJ , et al.. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 2019; 74:1823–1838.

• PubMed
Sarnak MJ , . Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 2019; 74:1823–1838.)| false
• Search Google Scholar
• Export Citation

Maini R , et al.. Persistent underrepresentation of kidney disease in randomized controlled trials of cardiovascular disease in the contemporary era. J Am Soc Nephrol 2018; 29:2782–2786.

• PubMed
Maini R , . Persistent underrepresentation of kidney disease in randomized controlled trials of cardiovascular disease in the contemporary era. J Am Soc Nephrol 2018; 29:2782–2786.)| false
• Search Google Scholar
• Export Citation

Marenzi G , et al.. Chronic kidney disease in acute coronary syndromes. World J Nephrol 2012; 1:134–145.

• PubMed
Marenzi G , . Chronic kidney disease in acute coronary syndromes. World J Nephrol 2012; 1:134–145.)| false
• Search Google Scholar
• Export Citation

Sosnov J , et al.. Differential symptoms of acute myocardial infarction in patients with kidney disease: A community-wide perspective. Am J Kidney Dis 2006; 47:378–384.

• PubMed
Sosnov J , . Differential symptoms of acute myocardial infarction in patients with kidney disease: A community-wide perspective. Am J Kidney Dis 2006; 47:378–384.)| false
• Search Google Scholar
• Export Citation

https://www.who.int/gho/women_and_health/mortality/situation_trends_causes_death/en/

• PubMed
https://www.who.int/gho/women_and_health/mortality/situation_trends_causes_death/en/ )| false
• Export Citation

Lynch M Women in clinical research through the years. https://www.fda.gov/consumers/womens-health-topics/women-clinical-trials.

• PubMed
Lynch M Women in clinical research through the years. https://www.fda.gov/consumers/womens-health-topics/women-clinical-trials .)| false
• Search Google Scholar
• Export Citation

EUGenMed Cardiovascular Clinical Study Group, et al.. Gender in cardiovascular diseases: Impact on clinical manifestations, management, and outcomes. Eur Heart J 2016; 37:24–34.

• PubMed
EUGenMed Cardiovascular Clinical Study Group, . Gender in cardiovascular diseases: Impact on clinical manifestations, management, and outcomes. Eur Heart J 2016; 37:24–34.)| false
• Search Google Scholar
• Export Citation

Women’s health and kidney disease. Nat Rev Nephrol 2018; 14:139.

• PubMed
Women’s health and kidney disease. Nat Rev Nephrol 2018; 14:139.)| false
• Search Google Scholar
• Export Citation

https://www.glaad.org/about.

• PubMed
https://www.glaad.org/about .)| false
• Export Citation

Streed CG , et al.. Cardiovascular disease among transgender adults receiving hormone therapy: A narrative review. Ann Intern Med 2017; 167:256–267.

• PubMed
Streed CG , . Cardiovascular disease among transgender adults receiving hormone therapy: A narrative review. Ann Intern Med 2017; 167:256–267.)| false
• Search Google Scholar
• Export Citation

Alzahrani T , et al.. Cardiovascular disease risk factors and myocardial infarction in the transgender population. Circ Cardiovasc Qual Outcomes 2019; 12:e005597.

• PubMed
Alzahrani T , . Cardiovascular disease risk factors and myocardial infarction in the transgender population. Circ Cardiovasc Qual Outcomes 2019; 12:e005597.)| false
• Search Google Scholar
• Export Citation

Whitley CT , Greene DN . Transgender man being evaluated for a kidney transplant. Clin Chem 2017; 63:1680–1684.

• PubMed
Whitley CT , Greene DN . Transgender man being evaluated for a kidney transplant. Clin Chem 2017; 63:1680–1684.)| false
• Search Google Scholar
• Export Citation

Whitley C . https://thebodyisnotanapology.com/magazine/the-amazing-failing-body-being-a-trans-person-with-kidney-disease-2/.

• PubMed
Whitley C . https://thebodyisnotanapology.com/magazine/the-amazing-failing-body-being-a-trans-person-with-kidney-disease-2/ .)| false
• Export Citation

SoRelle JA , et al.. Impact of hormone therapy on laboratory values in transgender patients. Clin Chem 2019; 65:170–179.

• PubMed
SoRelle JA , . Impact of hormone therapy on laboratory values in transgender patients. Clin Chem 2019; 65:170–179.)| false
• Search Google Scholar
• Export Citation

Review of the literature: Primary barriers and facilitators to participation in clinical research. https://orwh.od.nih.gov/sites/orwh/files/docs/orwh_outreach_toolkit_litreview.pdf.

• PubMed
Review of the literature: Primary barriers and facilitators to participation in clinical research. https://orwh.od.nih.gov/sites/orwh/files/docs/orwh_outreach_toolkit_litreview.pdf .)| false
• Search Google Scholar
• Export Citation